Russia completes development of cancer vaccine - what preclinical trials have shown

Russia is finalizing the development of a vaccine against cancer. Preclinical tests show that after the use of the novelty not only melanoma, but also metastases disappear. This was announced by the head of the Gamaleya Center for Epidemiology and Microbiology of the Russian Ministry of Health.

Gintsburg explained that the drug will be tested for interaction with other cancers - lung cancer, kidney cancer, pancreatic cancer. It is planned to make the vaccine for each patient individually.